Showing results (191-200 of 234) with videos related to
Sort By:
Pageof 24
Cancer Research|January 18, 2008
Cyclooxygenase-2 expression during immortalization and breast cancer progressionXiangshan Zhao, Monica Goswami, Nidhi Pokhriyal, et al.The Journal of Thoracic and Cardiovascular Surgery|May 1, 1995
Modulation of alloreactivity in transplant recipients by phenotypic manipulation of donor endotheliumR L Quigley, S S Switzer, T A Victor, et al.Journal of Surgical Oncology|July 1, 1987
Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials populationC F Mountain, J M Lukeman, S P Hammar, et al.Brain Structure & Function|June 11, 2017
Co-altered functional networks and brain structure in unmedicated patients with bipolar and major depressive disordersHao He, Jing Sui, Yuhui Du, et al.Blood|October 25, 2003
Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugsDylan T Jones, Elena Addison, Janet M North, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 31, 2014
Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorderJonathan Savitz, Wayne C Drevets, Chelsey M Smith, et al.BMJ Open|January 27, 2018
Tulsa 1000: a naturalistic study protocol for multilevel assessment and outcome prediction in a large psychiatric sampleTeresa A Victor, Sahib S Khalsa, W Kyle Simmons, et al.Brain, Behavior, and Immunity|February 18, 2015
Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorderJonathan Savitz, Wayne C Drevets, Brent E Wurfel, et al.British Journal of Haematology|July 9, 2003
Clinical trial of deferiprone iron chelation therapy in beta-thalassaemia/haemoglobin E patients in ThailandPensri Pootrakul, Pornpan Sirankapracha, Jongkal Sankote, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemiaForida Y Mortuza, Mary Papaioannou, Ilidia M Moreira, et al.Pageof 24